MP
IMPL

McDonald Partners’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

McDonald Partners’s Portfolio IMPL Stock Details IMPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,400
Closed -$8.34K – 233
2023
Q3 		$8.34K Sell
19,400
-800
-4% -$768 ﹤0.01% 227
2023
Q2 		$25.7K Buy
20,200
+8,500
+73% +$12.9K 0.01% 239
2023
Q1 		$16.4K Hold
11,700
– – 0.01% 235
2022
Q4 		$43.9K Buy
+11,700
New +$42.6K 0.02% 226

Other funds holding IMPL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

McDonald Partners's IMPL Position: Q4 2023 in Review

McDonald Partners sold out of Impel Pharmaceuticals Inc. Common Stock (IMPL) in Q4 2023, closing a stake of 19,400 shares — an estimated $8.34K sold.

McDonald Partners first reported a position in IMPL in Q4 2022 and held it in 4 quarters. The position peaked at $43.9K in Q4 2022. 2 funds tracked by Wall St. Rank hold IMPL as of Q4 2023.

  • McDonald Partners reported no remaining Impel Pharmaceuticals Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • McDonald Partners sold 19,400 Impel Pharmaceuticals Inc. Common Stock shares in Q4 2023, an estimated $8.34K.
  • McDonald Partners first reported a position in Impel Pharmaceuticals Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • McDonald Partners's Impel Pharmaceuticals Inc. Common Stock position peaked at $43.9K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Impel Pharmaceuticals Inc. Common Stock as of Q4 2023.

Based on McDonald Partners's 13F filing for Q4 2023, filed 12 Feb 2024.